Revision History
Galbot G1 · 9 revisions
Sizes are character counts of the article source. The signed number is the change from the previous revision.
Recent edit summaries
Detailed summaries recorded by editors. Generic maintenance summaries are omitted here; every recorded revision remains below. Dates describe the edit, not necessarily the event it covers.
- Update: added an official video.
Version 9 · Nov 1, 2026, 07:54 AM
- Correction: the G1 was first announced in 2024, not March 2025; pharmacy counts now dated to Galbot's mid-2025 statements
Version 8 · Oct 28, 2026, 08:37 AM
- Correction: G1 specifications aligned with Galbot's official spec page (92.5 kg, 8-hour runtime, 5 kg per arm, 21 DOF excluding base and end effectors, interchangeable end effectors, AGX Orin compute) instead of third-party aggregator ranges
Version 6 · Oct 28, 2026, 08:07 AM
- Correction: funding table now matches the body's June 2025 date for the CATL round; the release sentence now matches its cited source, which dates the G1 release to March 2025; Ramesohl's title per the cited release is managing partner
Version 5 · Aug 4, 2026, 11:11 PM
- Correction: GraspVLA first author is Deng Shengliang (was misnamed Jia); removed an unverifiable Peking University bachelor claim (sources conflict); fixed the March 2026 round investors per TechNode/Caixin; linked the new Galbot company page; June 2025 round date precision
Version 4 · Aug 4, 2026, 10:36 PM